Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ebru, Oruç"'
Publikováno v:
Turkish Journal of Nephrology, Vol 31, Iss 2, Pp 165-170 (2022)
Externí odkaz:
https://doaj.org/article/4b8bdce3824e4a5e855dd4924031cc59
Publikováno v:
Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 11, Iss 1 (2022)
Introduction: Healthcare-associated infections (HCAIs) have increased during the COVID-19 pandemic due to inadequate adherence to infection control measures. Central-line-associated bloodstream infections (CLBSI) are one of the infections with an inc
Externí odkaz:
https://doaj.org/article/01095fabdf6946f2ac2460ce55d88396
Autor:
Çiğdem Erol, Zeynep Ece Kuloğlu, Bircan Kayaaslan, Gülen Esken, Adalet Altunsoy, Tayfun Barlas, Güle Çınar, İmran Hasanoğlu, Ebru Oruç, Said İncir, Alpay Azap, Gülten Korkmaz, Dilara Turan Gökçe, Onur Elvan Kırımker, Ezgi Coşkun Yenigün, Erkan Ölçücüoğlu, Ebru Ayvazoğlu Soy, Süleyman Çetinkünar, Özlem Kurt Azap, Füsun Can, Mehmet Haberal
Publikováno v:
Viruses, Vol 15, Iss 7, p 1534 (2023)
We evaluated neutralizing antibodies against the Omicron variant and Anti-Spike IgG response in solid organ (SOT) or hematopoietic stem cell (HSTC) recipients after a third dose of BNT162b2 (BNT) or CoronaVac (CV) following two doses of CV. In total,
Externí odkaz:
https://doaj.org/article/be9ce951a83742f28394dac5a80914cd
Autor:
Tuğba Arslan Gülen, Mustafa Oğuz Tuğcan, Tuba Turunç, Ahmet Burak Urfalıoğlu, Bedia Mutay Suntur, Ebru Oruç, Akkan Avcı
Publikováno v:
Flora the Journal of Infectious Diseases and Clinical Microbiology. 27:545-554
Publikováno v:
Mediterranean Journal of Infection Microbes and Antimicrobials.
Autor:
Çiğdem Erol, Zeynep Ece Kuloğlu, Bircan Kayaaslan, Gülen Esken, Adalet Altınsoy, Tayfun Barlas, Güle Çınar, İmran Hasanoğlu, Ebru Oruç, Said İncir, Alpay Azap, Gülten Korkmaz, Dilara Turan Gökçe, Onur Elvan Kırımker, Ezgi Coşkun Yenigün, Erkan Ölçücüoğlu, Ebru Ayvazoğlu Soy, Süleyman Çetinkünar, Özlem Kurt Azap, Füsun Can, Mehmet Haberal
Introduction: We evaluated neutralizing antibody and anti-spike antibody (anti-S) response against omicron variant in solid organ (SOT) or hematopoietic stem cell (HSTC) receivers after third dose of BNT162b2 (BNT) or CoronaVac (CV) following two dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d02bb9efdf12ec1af5cf6247079bab1
https://doi.org/10.21203/rs.3.rs-2316160/v1
https://doi.org/10.21203/rs.3.rs-2316160/v1
Publikováno v:
Dicle Medical Journal, Vol 48, Iss 3, Pp 488-497 (2021)
Volume: 48, Issue: 3 488-497
Dicle Tıp Dergisi
Volume: 48, Issue: 3 488-497
Dicle Tıp Dergisi
Objective: Although pulmonary aspergillosis (PA) is often seen in patients with immunodeficiency, it also identifies a number of clinical diseases that cause morbidity and mortality, which can also occur in patients with immunodeficiency. The aim of
Autor:
Celal, Ayaz, Mustafa Kemal, Çelen, Tuba, Dal, Özcan, Deveci, Kadim, Bayan, Duygu, Mert, Ebru, Oruç, Nida, Özcan, Idris, Kandemir, Mehmet Sinan, Dal
Publikováno v:
Le infezioni in medicina. 23(1)
Tenofovir disoproxil fumarate (Tenofovir DF) is a nucleotide analogue. This multicentre study reports retrospectively the long-term efficacy and safety data with tenofovir DF treatment in nucleosid(t)e-naive, hepatitis B e antigen (HBeAg)-positive ch